Similar articles for PMID: 34697173

Year	Number of Results
2000	1
2003	1
2005	3
2007	2
2008	2
2009	2
2010	9
2011	6
2012	10
2013	6
2014	5
2015	6
2016	12
2017	4
2018	11
2019	17
2020	9
2021	9
2022	8
2023	2
2024	0

1

Clinical Outcomes of Hydrogel Spacer Injection Space OAR in Men Submitted to Hypofractionated Radiotherapy for Prostate Cancer.

Pepe P, Tamburo M, Pennisi M, Marletta D, Marletta F. Pepe P, et al. In Vivo. 2021 Nov-Dec;35(6):3385-3389. doi: 10.21873/invivo.12637. In Vivo. 2021. PMID: 34697173 Free PMC article.

2

Erectile dysfunction following hydrogel injection and hypofractionated radiotherapy for prostate cancer: Our experience in 56 cases.

Pepe P, Tamburo M, Panella P, Pepe L, Marletta G, Pennisi M, Marletta F. Pepe P, et al. Arch Ital Urol Androl. 2022 Jun 29;94(2):166-168. doi: 10.4081/aiua.2022.2.166. Arch Ital Urol Androl. 2022. PMID: 35775340 Free article.

3

Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415.

Thor M, Deasy JO, Paulus R, Robert Lee W, Amin MB, Bruner DW, Low DA, Shah AB, Malone SC, Michalski JM, Dayes IS, Seaward SA, Gore EM, Albert M, Pisansky TM, Faria SL, Chen Y, Koontz BF, Swanson GP, Pugh SL, Sandler HM. Thor M, et al. Radiother Oncol. 2019 Jun;135:19-24. doi: 10.1016/j.radonc.2019.02.014. Epub 2019 Mar 5. Radiother Oncol. 2019. PMID: 31015166 Free PMC article.

4

Prostate hypofractionated radiotherapy (62Gy at 3.1Gy per fraction) with injection of hyaluronic acid: final results of the RPAH1 study.

Chapet O, Udrescu C, Bin S, Decullier E, Fenoglietto P, Beneux A, Segui B, Enachescu C, Gaudioz S, Ruffion A, Azria D. Chapet O, et al. Br J Radiol. 2021 Aug 1;94(1124):20210242. doi: 10.1259/bjr.20210242. Br J Radiol. 2021. PMID: 34282946 Free PMC article. Clinical Trial.

5

Hypofractionated Radiation Therapy to the Prostate Bed With Intensity-Modulated Radiation Therapy (IMRT): A Phase 2 Trial.

Leite ETT, Ramos CCA, Ribeiro VAB, Salvajoli BP, Nahas WC, Salvajoli JV, Ynoe Moraes F. Leite ETT, et al. Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1263-1270. doi: 10.1016/j.ijrobp.2020.12.020. Epub 2020 Dec 17. Int J Radiat Oncol Biol Phys. 2021. PMID: 33346091 Clinical Trial.

6

Acute and Late Toxicity after Moderate Hypofractionation with Simultaneous Integrated Boost (SIB) Radiation Therapy for Prostate Cancer. A Single Institution, Prospective Study.

Jorgo K, Polgar C, Major T, Stelczer G, Herein A, Pocza T, Gesztesi L, Agoston P. Jorgo K, et al. Pathol Oncol Res. 2020 Apr;26(2):905-912. doi: 10.1007/s12253-019-00623-2. Epub 2019 Mar 19. Pathol Oncol Res. 2020. PMID: 30888646 Free PMC article. Clinical Trial.

7

Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.

Peeters ST, Heemsbergen WD, van Putten WL, Slot A, Tabak H, Mens JW, Lebesque JV, Koper PC. Peeters ST, et al. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1019-34. doi: 10.1016/j.ijrobp.2004.07.715. Int J Radiat Oncol Biol Phys. 2005. PMID: 15752881 Clinical Trial.

8

Image Guided Hypofractionated Postprostatectomy Intensity Modulated Radiation Therapy for Prostate Cancer.

Lewis SL, Patel P, Song H, Freedland SJ, Bynum S, Oh D, Palta M, Yoo D, Oleson J, Salama JK. Lewis SL, et al. Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):605-11. doi: 10.1016/j.ijrobp.2015.11.025. Epub 2015 Dec 2. Int J Radiat Oncol Biol Phys. 2016. PMID: 26867889

9

Early Tolerance and Tumor Control Outcomes with High-dose Ultrahypofractionated Radiation Therapy for Prostate Cancer.

Zelefsky MJ, Pinitpatcharalert A, Kollmeier M, Goldman DA, McBride S, Gorovets D, Zhang Z, Varghese M, Happersett L, Tyagi N, Hunt M. Zelefsky MJ, et al. Eur Urol Oncol. 2020 Dec;3(6):748-755. doi: 10.1016/j.euo.2019.09.006. Epub 2019 Oct 23. Eur Urol Oncol. 2020. PMID: 31668713 Free PMC article. Clinical Trial.

10

Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.

Akimoto T, Ito K, Saitoh J, Noda SE, Harashima K, Sakurai H, Nakayama Y, Yamamoto T, Suzuki K, Nakano T, Niibe H. Akimoto T, et al. Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):463-71. doi: 10.1016/j.ijrobp.2004.11.041. Int J Radiat Oncol Biol Phys. 2005. PMID: 16168838

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year